Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-17-005923
Filing Date
2017-05-25
Accepted
2017-05-25 16:56:56
Documents
3
Effectiveness Date
2017-05-25
Reference 429
333-196487

Document Format Files

Seq Description Document Type Size
1 S-8 forms-8.htm S-8 101301
2 EXHIBIT 5.1 exhibit51legalopinion.htm EX-5.1 7444
3 EXHIBIT 23.1 exhibit231eyconsent.htm EX-23.1 4038
  Complete submission text file 0001628280-17-005923.txt   113863
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-218239 | Film No.: 17870765
SIC: 2834 Pharmaceutical Preparations